Collagen Solutions PLC Grant of Options (9799W)

TIDMCOS

RNS Number : 9799W

Collagen Solutions PLC

15 February 2017

Collagen Solutions plc

("Collagen Solutions", the "Company" or the "Group")

15 February 2017

Grant of Options

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that options over 500,000 ordinary shares of 1p each in the Company ("Ordinary Shares") were granted today to Kevin Darling, General Manager (New Zealand) ("Options").

The Options have an exercise period of ten years from grant and have an exercise price per Option of 5.625p. The Options vest in full upon the closing middle market price per Ordinary Share exceeding 27p or EPS for the relevant financial year achieving 1p during the exercise period.

- Ends -

Enquiries:

 
                                               Contact via Walbrook 
   Collagen Solutions Plc 
 Jamal Rushdy, Chief Executive 
  Officer 
 Gill Black, Chief Financial 
  Officer 
 
 Cenkos Securities plc (Nominated                Tel: [phone] 
  Adviser and Broker) 
  Stephen Keys 
  Steve Cox 
  Callum Davidson 
 
 Walbrook PR                           Tel: [phone] or 
                                       [e-mail] 
 Mike Wort                                       Mob: [phone] 
 Anna Dunphy                                     Mob: [phone] 
 
 
 
 1    Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ----------------------------------------------------------- 
 a)   Name                       Kevin Darling 
---  -------------------------  -------------------------------- 
 2    Reason for the notification 
---  ----------------------------------------------------------- 
 a)   Position/status            General Manager, New Zealand 
                                  - Executive Team Member 
---  -------------------------  -------------------------------- 
 b)   Initial notification 
       /Amendment                  Initial Notification 
---  -------------------------  -------------------------------- 
 3    Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ----------------------------------------------------------- 
 a)   Name                       Collagen Solutions Plc 
---  -------------------------  -------------------------------- 
 b)   LEI                        N/A 
---  -------------------------  -------------------------------- 
 4    Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ----------------------------------------------------------- 
 a)   Description of 
       the financial               Option to acquire 1p ordinary 
       instrument, type            shares in Collagen Solutions 
       of instrument               Plc 
 
                                   N/A 
       Identification 
       code 
---  -------------------------  -------------------------------- 
 b)   Nature of the              Grant of Options 
       transaction 
---  -------------------------  -------------------------------- 
 c)   Price(s) and volume(s)     Price (exercise): 5.625p 
                                  Volume(s): 500,000 
---  -------------------------  -------------------------------- 
 d)   Aggregated information 
 
       - Aggregated volume         N/A 
 
       - Price                     N/A 
---  -------------------------  -------------------------------- 
 e)   Date of the transaction    15 February 2017 
---  -------------------------  -------------------------------- 
 f)   Place of the transaction   Outside a trading venue 
---  -------------------------  -------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHOKPDBDBKDOBD

(END) Dow Jones Newswires

February 15, 2017 06:29 ET (11:29 GMT)